Benzinga - Gainers
- CXApp Inc. (NASDAQ: CXAI) jumped 318% to $29.80 in pre-market trading after gaining more than 345% on Thursday.
- SAI.TECH Global Corporation (NASDAQ: SAI) gained 211% to $4.73 in pre-market trading after gaining around 25% on Thursday.
- Inpixon (NASDAQ: INPX) surged 106% to $1.49 in pre-market trading after jumping around 128% on Thursday.
- Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) climbed 98.2% to $2.24 in pre-market trading.
- SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares climbed 54.3% to $3.50 in pre-market trading after jumping 37% on Thursday.
- Marpai, Inc. (NASDAQ: MRAI) gained 41% to $2.30 in pre-market trading after gaining 90% on Thursday.
- LogicMark, Inc. (NASDAQ: LGMK) gained 24.7% to $0.1970 in pre-market trading after gaining around 8% on Thursday.
- G Medical Innovations Holdings Ltd (NASDAQ: GMVD) gained 23.7% to $0.6572 in pre-market trading. G Medical Innovations recently announced closing of public offering.
- Navidea Biopharmaceuticals, Inc. (NASDAQ: NAVB) gained 16.5% to $0.3035 in pre-market trading. Navidea Biopharmaceuticals entered into $750,000 asset purchase agreement with Meilleur Technologies for rights to NAV4694.
- Freight Technologies, Inc. (NASDAQ: FRGT) climbed 15.7% to $3.02 in pre-market trading after declining 9% on Thursday. Freight Technologies recently regained compliance with Nasdaq listing rule.
- Navidea Biopharmaceuticals (NASDAQ: NCMI) fell 27% to $0.3124 in pre-market trading. The company recently filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas. The company announced a series of debt restructuring transactions likely to strengthen its balance sheet meaningfully and position it for long-term growth.
- Pear Therapeutics, Inc. (NASDAQ: PEAR) shares dropped 24.4% to $0.0896 in pre-market trading. Pear Therapeutics recently filed for Chapter 11 and said it will seek to sell its assets through a sales process.
- PARTS iD, Inc. (NYSE: ID) fell 21.9% to $0.1926 in pre-market after dropping over 5% on Thursday.
- SAB Biotherapeutics, Inc. (NASDAQ: SABS) fell 20.5% to $0.6029 in pre-market trading. SAB Therapeutics shares jumped around 98% on Thursday after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza.
- Meta Materials Inc. (NASDAQ: MMAT) fell 20.2% to $0.3050 in pre-market trading after the company reported a proposed public offering.
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell 18.8% to $0.47 in pre-market trading. Panbela Therapeutics recently announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
- Kalera Public Limited Company (NASDAQ: KAL) fell 17.3% to $1.34 in pre-market trading after dropping 14% on Thursday. Kalera recently received a notice of delisting form Nasdaq.
- Wheels Up Experience Inc. (NYSE: UP) fell 17.1% to $0.44 in pre-market trading after gaining around 27% on Thursday.
- HeartCore Enterprises, Inc. (NASDAQ: HTCR) fell 15.1% to $1.01 in pre-market trading after dropping 15% on Thursday. HeartCore Enterprises recently announced it signed its tenth Go IPO contract.
- Knightscope, Inc. (NASDAQ: KSCP) shares fell 13.6% to $0.55 in pre-market trading after dropping over 6% on Thursday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.